799 related articles for article (PubMed ID: 11729723)
21. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
[TBL] [Abstract][Full Text] [Related]
22. [Usefulness of percutaneous transluminal angioplasty of lesions in saphenous vein graft].
Yasuda H; Hiraishi T; Kobayashi T
Nihon Kyobu Geka Gakkai Zasshi; 1996 Sep; 44(9):1729-34. PubMed ID: 8911046
[TBL] [Abstract][Full Text] [Related]
23. [Comparative study of aorto-coronary bypass surgery using internal mammary artery grafts and saphenous vein grafts].
Moriya H; Yasuura K; Okamoto H; Matsuura A; Akita T; Watanabe T; Takeuchi E; Tanaka M; Abe T; Seki A
Kyobu Geka; 1990 Jan; 43(1):13-8. PubMed ID: 2304292
[TBL] [Abstract][Full Text] [Related]
24. Intermediate-term patency of saphenous vein graft with a clampless hand-sewn proximal anastomosis device after off-pump coronary bypass grafting.
Shimokawa T; Manabe S; Sawada T; Matsuyama S; Fukui T; Takanashi S
Ann Thorac Surg; 2009 May; 87(5):1416-20. PubMed ID: 19379877
[TBL] [Abstract][Full Text] [Related]
25. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions.
Jeger RV; Schneiter S; Kaiser C; Bonetti PO; Brunner-La Rocca H; Handke M; Osswald S; Buser PT; Pfisterer ME;
Cardiology; 2009; 112(1):49-55. PubMed ID: 18580059
[TBL] [Abstract][Full Text] [Related]
26. "Hybrid" percutaneous and surgical coronary revascularization: selection criteria from a single-center experience.
Presbitero P; Nicolini F; Maiello L; Franciosi G; Carcagni A; Milone F; Manasse E; Gallotti R
Ital Heart J; 2001 May; 2(5):363-8. PubMed ID: 11392640
[TBL] [Abstract][Full Text] [Related]
27. Clinical, angiographic, and interventional follow-up of patients with aortic-saphenous vein graft connectors.
Traverse JH; Mooney MR; Pedersen WR; Madison JD; Flavin TF; Kshettry VR; Henry TD; Eales F; Joyce LD; Emery RW
Circulation; 2003 Jul; 108(4):452-6. PubMed ID: 12860909
[TBL] [Abstract][Full Text] [Related]
28. Arterial conduit shear stress following bypass grafting for intermediate coronary artery stenosis: a comparative study with saphenous vein grafts.
Shimizu T; Ito S; Kikuchi Y; Misaka M; Hirayama T; Ishimaru S; Yamashina A
Eur J Cardiothorac Surg; 2004 Apr; 25(4):578-84. PubMed ID: 15037275
[TBL] [Abstract][Full Text] [Related]
29. [Long-term results in 1,400 patients with coronary artery bypass grafting: saphenous vein vs arterial grafts].
Nishida H; Hirota J; Koyanagi T; Abe R; Nakano K; Endo M; Koyanagi H
Kyobu Geka; 1992 Jul; 45(8 Suppl):660-4. PubMed ID: 1405140
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous intervention of acutely occluded saphenous vein grafts: contemporary techniques and outcomes.
Abdel-Karim AR; Banerjee S; Brilakis ES
J Invasive Cardiol; 2010 Jun; 22(6):253-7. PubMed ID: 20516502
[TBL] [Abstract][Full Text] [Related]
31. [Angioplasty for vein grafts and native coronary arteries after previous coronary artery bypass grafting].
Avital S; Wacksman R; Rozenman Y; Mosseri M; Lotan C; Hasin Y; Gotsman MS
Harefuah; 1995 Aug; 129(3-4):96-9, 159. PubMed ID: 8543249
[TBL] [Abstract][Full Text] [Related]
32. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting.
de Cannière D; Jansens JL; Goldschmidt-Clermont P; Barvais L; Decroly P; Stoupel E
Am Heart J; 2001 Oct; 142(4):563-70. PubMed ID: 11579343
[TBL] [Abstract][Full Text] [Related]
33. Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: comparison of early with recent results in small children.
Tsuda E; Kitamura S; Kimura K; Kobayashi J; Miyazaki S; Echigo S; Yagihara T
Am Heart J; 2007 Jun; 153(6):995-1000. PubMed ID: 17540201
[TBL] [Abstract][Full Text] [Related]
34. Saphenous vein graft disease.
Peykar S; Angiolillo DJ; Bass TA; Costa MA
Minerva Cardioangiol; 2004 Oct; 52(5):379-90. PubMed ID: 15514573
[TBL] [Abstract][Full Text] [Related]
35. Single versus bilateral internal mammary artery for isolated first myocardial revascularization in multivessel disease: long-term clinical results in medically treated diabetic patients.
Calafiore AM; Di Mauro M; Di Giammarco G; Teodori G; Iacò AL; Mazzei V; Vitolla G; Contini M
Ann Thorac Surg; 2005 Sep; 80(3):888-95. PubMed ID: 16122450
[TBL] [Abstract][Full Text] [Related]
36. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
37. Blood loss and use of blood in internal mammary artery and saphenous vein bypass grafting with and without adding a single, low-dose of aprotinin (2 million units) to the pump prime.
Schönberger JP; van Zundert A; Bredée JJ; Gardien M; Everts PA; Bavinck JH; Berreklouw E; Wildevuur CR
Acta Anaesthesiol Belg; 1992; 43(3):187-96. PubMed ID: 1280395
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results].
Lozano I; García-Camarero T; Carrillo P; Baz JA; de la Torre JM; López-Palop R; Pinar E; Salvatella N; Avanzas P; Valdés M
Rev Esp Cardiol; 2009 Jan; 62(1):39-47. PubMed ID: 19150013
[TBL] [Abstract][Full Text] [Related]
39. Stenting of partial and total coronary occlusions in Trinidad and Tobago.
Thomas CN; Williams DH; Hinds A; Daniel S; Ryan F; Ramroop C; Nath CF; Crosby D
West Indian Med J; 2001 Mar; 50(1):22-6. PubMed ID: 11398282
[TBL] [Abstract][Full Text] [Related]
40. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.
Ellis SG; Kandzari D; Kereiakes DJ; Pichard A; Huber K; Resnic F; Yakubov S; Callahan K; Borgman M; Cohen SA
J Invasive Cardiol; 2007 Oct; 19(10):404-9. PubMed ID: 17906340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
